Richard D Friend, MD | |
850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7419 | |
(205) 348-1770 | |
(205) 348-1772 |
Full Name | Richard D Friend |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 31 Years |
Location | 850 Peter Bryce Blvd, Tuscaloosa, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023038684 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 18480 (Mississippi) | Secondary |
207Q00000X | Family Medicine | 10815R (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capstone Health Services Foundation Pc | 6103724489 | 120 |
News Archive
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).
The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.
Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.
Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.
› Verified 6 days ago
Entity Name | Capstone Health Services Foundation Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740397751 PECOS PAC ID: 6103724489 Enrollment ID: O20040330001160 |
News Archive
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).
The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.
Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.
Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.
› Verified 6 days ago
Entity Name | Paragon Contracting Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).
The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.
Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.
Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Richard D Friend, MD 850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7419 Ph: (205) 348-1770 | Richard D Friend, MD 850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7419 Ph: (205) 348-1770 |
News Archive
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).
The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.
Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.
Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.
› Verified 6 days ago
Dr. Ashok V Mujumdar, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-554-4196 Fax: 205-554-4196 | |
Tameka Carmichael Hairston, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-1772 | |
Dr. Subhod Rao, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 5th Ave E, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-7216 | |
Dorian Christine Bonam, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2730 M. L King Jr Blvd, Tuscaloosa, AL 35403 Phone: 205-349-3250 | |
Dr. Stephen A Roberts, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1771 Skyland Blvd E, Tuscaloosa, AL 35405 Phone: 205-553-0199 Fax: 205-553-3024 | |
David Maxwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 750 5th Avenue East, Tuscaloosa, AL 35401 Phone: 205-348-6262 Fax: 205-348-0630 |